-
-
Call more information
660-596-2224 -
Authors: Debryna D. Lumanauw MD et al Academic Emergency Medicine March 2019 Background Subdissociative‐dose ketamine (SDDK) is used to treat acute pain. We sought to determine if SDDK is effective in relieving acute exacerbations of chronic pain. Methods This study was a randomized double‐blind placebo‐controlled trial conducted May 2017 to June 2018 at a public […]
Read MoreAuthor: Michael Gennett Polsinelli Medicare providers who have overpayments with pending requests for Administrative Law Judge (ALJ) hearings filed on or before March 31, 2019 may now take advantage of the renewed Settlement Conference Facilitation (SCF) program. This program allows the providers to meet with CMS representatives to discuss the possibility of a mutually agreeable […]
Read MoreAuthor: Bob Kronemyer Anesthesiology News Although patients undergoing cardiovascular surgery with persistent opioid use or dependence have roughly the same mortality rate as those without (3.1% vs. 4.0%), the opioid group experiences a higher number of complications overall, a longer hospital length of stay and higher costs, according to a large retrospective population-based cohort study. […]
Read MoreAuthors: Grunau B et al. Ann Emerg Med 2019 Jun 24 A large observational study found that shorter intervals (<3 minutes) were associated with increased odds of survival with good neurologic function. Guidelines advise giving epinephrine every 3 to 5 minutes during cardiac arrest, but there is no evidence to support this dosing frequency. To study […]
Read MoreThe extended-release local anaesthetic liposomal bupivacaine, commonly used in various surgical sites in adults, shows safety and efficacy in children and adults alike for control of pain with neurosurgery, according to a study presented here at the 2019 Annual Meeting of the American Association of Neurological Surgeons (AANS). “Our findings show liposomal bupivacaine was not […]
Read More